KEELY ALLEN: Open Payments
NPI 1487309324 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 65 payments from 20 companies in 2025. Trend: 2023 $731 · 2024 $1,055 · 2025 $1,165
Food & beverage: $1,165
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $282 |
| GlaxoSmithKline, LLC. | 15 | $170 |
| Novo Nordisk Inc | 13 | $145 |
| Lilly USA, LLC | 7 | $117 |
| Abbott Laboratories | 4 | $64 |
| ABBVIE INC. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| Organon LLC | 3 | $43 |
| SANOFI PASTEUR INC. | 2 | $32 |
| SHIELD THERAPEUTICS INC | 1 | $30 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, MOUNJARO, Wegovy, Ozempic, FREESTYLE LIBRE 3, JARDIANCE, NEXPLANON.
Industry payments across OK — which companies pay providers there.
